Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

384396

registered interest
date	19/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Social Services: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if his Department will update its impact assessment for funding reform to care and support services in England to take account of the Government's policy to increase inheritance tax thresholds by 2020.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	3345
answer	answer is ministerial correction date of answer 29/06/2015 answer text <p>The Impact Assessment for funding reform to care and support sets out the costs and benefits of the reforms and was last updated in February 2013 to support the consultation on draft regulations and guidance. A final Impact Assessment will be published alongside the final regulations and guidance.</p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 29/06/2015 15:17:25 answering member 1201 label Biography information for Alistair Burt
tabling member	1538 label Biography information for Rosie Cooper

348397

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa: Health Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to raise awareness of hidradenitis suppurativa.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	962
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 963 964 965 question first answered 08/06/2015 10:53:58 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

348398

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate his Department has made of the number of people with hidradenitis suppurativa in the UK; how much his Department has spent on research into hidradenitis suppurativa in the last four years; and what guidance his Department gives on support to be given through the NHS for people with hidradenitis suppurativa.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	963
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 962 964 965 question first answered 08/06/2015 10:54:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

348399

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the effectiveness of the care pathways for patients with hidradenitis suppurativa.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	964
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 962 963 965 question first answered 08/06/2015 10:54:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

348400

registered interest
date	03/06/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hidradenitis Suppurativa: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken to provide information to surgeons, dermatologists and general practitioners about hidradenitis suppurativa.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	965
answer	answer is ministerial correction date of answer 08/06/2015 answer text <p>Hidradenitis suppurativa (HS) affects around 90,000 people in England. The Department’s National Institute for Health Research Clinical Research Network (CRN) is providing research infrastructure to enable molecular genetic analysis of HS, although expenditure on this cannot be disaggregated from total CRN spend.</p><p> </p><p><br> Information on the diagnosis, treatment care and support of patients with HS can be found on the NHS Choices website. This also provides links to the British Association of Dermatologists, which has produced a patient information leaflet on HS, and the HS Trust, which is the United Kingdom‘s leading charity for the condition. More information can be found at the following link:</p><p> </p><p><br> <a href="http://www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx" target="_blank">www.nhs.uk/conditions/hidradenitis-suppurativa/Pages/Introduction.aspx</a></p><p> </p><p><br> In terms of the care pathway for the condition, HS can usually be managed with treatments including antibiotics, antiseptic washes and immunosuppressive treatments such as steroids or ciclosporin, which a general practitioner may prescribe. For those patients with the most serious forms of HS who cannot be managed through routine access to treatments provided through primary or secondary care, a referral to a specialised dermatology service may be appropriate. NHS England commissions services for people with rare and complex skin conditions and has set out what providers must have in place in order to offer specialist dermatology care. These services may provide more intensive therapies with the involvement of a range of health and care professionals, subject to a patient’s needs. More information can be found at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/a12-spec-dermatology.pdf</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 962 963 964 question first answered 08/06/2015 10:54:01 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

229457

registered interest
date	19/03/2015
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Youth Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, what steps he is taking to support youth services.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	908320
answer	answer is ministerial correction date of answer 25/03/2015 answer text <p>We continue to offer practical support to the youth sector by promoting innovative delivery models for youth services and supporting organisations to measure their impact and demonstrate their value.</p><p>We have also provided over 130,000 opportunities for young people through National Citizen Service.</p><p> </p> answering member constituency Reading East answering member printed Mr Rob Wilson grouped question UIN 908317 908319 question first answered 25/03/2015 17:29:38 answering member 1556 label Biography information for Mr Rob Wilson
tabling member	1538 label Biography information for Rosie Cooper

228318

registered interest
date	18/03/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS Trusts: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many NHS trusts have (a) responded to the request from NHS England and Monitor to choose between the Enhanced Tariff Option and the Default Tariff Rollover for 2015-16 and (b) reserved the right to challenge those new tariff arrangements.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	228202
answer	answer is ministerial correction date of answer 23/03/2015 answer text <p>A total of 211 out of 241 NHS trusts and foundation trusts (88% of all providers) have opted for the Enhanced Tariff Option (ETO). Of these, 90 were NHS trusts as opposed to NHS foundation trusts. Four NHS trusts wrote to Monitor reserving their right to legal challenge (one of whom had chosen the ETO option but placed conditions on this). The remaining NHS providers have either chosen or defaulted to the Default Tariff Rollover option.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/03/2015 17:34:23 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

223315

registered interest
date	24/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the Government is doing to support endoscopy units to ensure that there is sufficient capacity in resources and staff for the roll-out of the bowel scope screening programme.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	225126
answer	answer is ministerial correction date of answer 27/02/2015 answer text <p>Between May 2010 and November 2014, we have seen a 29.1% increase in consultant gastroenterologists, from 1,788 to 2,302.</p><p> </p><p> </p><p> </p><p><em>Delivering high quality, effective, compassionate care: Developing the right people with the right skills and the right values - A mandate from the Government to Health Education England: April 2014 to March 2015</em> states that Health Education England (HEE) will work with key partners to ensure that the National Health Service has available the right number of trained staff to deliver current and future demand for diagnostic tests. In particular, HEE will work with Public Health England and NHS England to ensure the availability of sufficient endoscopists to deliver bowel scope screening.</p><p> </p><p> </p><p> </p><p>A Joint Endoscopy Working Group, set up by NHS England's National Clinical Director for Diagnostics and Imaging, has been analysing the latest data, and an action plan is being developed to ensure sufficient capacity in the short and long term. The action plan will cover a wide range of organisations including HEE, NHS England, clinical commissioning groups and providers of endoscopy services. Potential actions identified include: developing robust endoscopy capacity and demand data; a national workforce strategy for endoscopy; supporting the training of non-medical endoscopists; including sufficient endoscopy capacity in business planning; and identifying new pathways and models of working.</p><p> </p><p> </p><p> </p><p>In addition NHS Improving Quality has developed The Productive Endoscopy Series, a set of self-directed learning resources that will help all staff working in endoscopy units to make better use of existing resources and deliver a more efficient and effective service to patients seven days a week.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/02/2015 13:59:23 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

223316

registered interest
date	24/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people have (a) been invited to take part in and (b) taken part in (i) the bowel scope screening programme and (ii) the faecal occult blood test programme to date.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	225127
answer	answer is ministerial correction date of answer 27/02/2015 answer text <p>As at the end of January 2015, 83,153 invitations have been issued and 28,674 Bowel Scope Screening procedures have been performed. Uptake stood at approximately 44% and ranged from 38% in the lowest site to 51% in the highest. 1,173 people had been referred to colonoscopy following a Bowel Scope Screening with 29 cancers detected and 541 high/immediate risk polyps and 413 low risk polyps removed.</p><p> </p><p> </p><p> </p><p>The Bowel Scope Screening Programme is progressing well, having exceeded the Secretary of State’s commitment to have the programme rolled out to 30% of screening centres by the end of March 2014 and is on target to meet the 60% commitment by the end of March 2015. Around 28 centres now offer Bowel Scope Screening.</p><p> </p><p> </p><p> </p><p>At the end of January 2015, nearly 25 million Faecal Occult Blood test kits had been sent out to men and women aged 60-74 to self-sample at home. Over 15 million kits have been returned by post to one of 5 regional labs (programme hubs). Since the Programmes began in 2006, over 21,000 cancers have been detected and over 122,000 patients have been managed for polyps, including polyp removal.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/02/2015 14:07:08 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

222986

registered interest
date	23/02/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal System
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that patients have timely and direct access to (a) gastroenterologists and (b) other specialist clinicians.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	224974
answer	answer is ministerial correction date of answer 26/02/2015 answer text <p>Health Education England (HEE) is responsible for workforce planning and education commissioning activity to ensure that the National Health Service in England has available a future workforce in the right numbers, with the right skills, values and behaviours.</p><p> </p><p> </p><p> </p><p>In December 2014, HEE published its second national Workforce Plan for England for the period 2015/16 which is built upon the needs of local employers, commissioners and other stakeholders. The priorities in the plan are the priorities of the NHS, identified locally and nationally by employers, professional bodies and other stakeholders.</p><p> </p><p> </p><p> </p><p>National recruitment into gastroenterology training posts in 2013 and 2014 achieved 100% fill-rate. There have been no reductions in the planned commissions of gastroenterologists for 2015/16.</p><p> </p><p> </p><p> </p><p>The following table shows the number of full-time equivalent doctors and gastroenterologists, excluding locums, working in hospital and community health services in England.</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Full-Time Equivalent</p></td><td><p>May 2010</p></td><td><p>November 2014</p></td><td colspan="2"><p>Change May 2010 to November 2014</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>All Doctors</p></td><td><p>95,421</p></td><td><p>105,001</p></td><td><p>9,580</p></td><td><p>10.0%</p></td></tr><tr><td><p><em>of which, with specialty of:</em></p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Gastroenterology</p></td><td><p>1,788</p></td><td><p>2,309</p></td><td><p>521</p></td><td><p>29.1%</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr></tbody></table><p> </p><p><em> </em></p><p> </p><p><em>Source:</em> Health and Social Care Information Centre, Monthly Workforce Statistics, Nov 2014</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 224978 question first answered 26/02/2015 11:35:36 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	1538 label Biography information for Rosie Cooper